Cargando…
The impact of integrated disease management in high-risk COPD patients in primary care
Patients with chronic obstructive pulmonary disease (COPD) have a reduced quality of life (QoL) and exacerbations that drive health service utilization (HSU). A majority of patients with COPD are managed in primary care. Our objective was to evaluate an integrated disease management, self-management...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6438975/ https://www.ncbi.nlm.nih.gov/pubmed/30923313 http://dx.doi.org/10.1038/s41533-019-0119-9 |
_version_ | 1783407184917299200 |
---|---|
author | Ferrone, Madonna Masciantonio, Marcello G. Malus, Natalie Stitt, Larry O’Callahan, Tim Roberts, Zofe Johnson, Laura Samson, Jim Durocher, Lisa Ferrari, Mark Reilly, Margo Griffiths, Kelly Licskai, Christopher J. |
author_facet | Ferrone, Madonna Masciantonio, Marcello G. Malus, Natalie Stitt, Larry O’Callahan, Tim Roberts, Zofe Johnson, Laura Samson, Jim Durocher, Lisa Ferrari, Mark Reilly, Margo Griffiths, Kelly Licskai, Christopher J. |
author_sort | Ferrone, Madonna |
collection | PubMed |
description | Patients with chronic obstructive pulmonary disease (COPD) have a reduced quality of life (QoL) and exacerbations that drive health service utilization (HSU). A majority of patients with COPD are managed in primary care. Our objective was to evaluate an integrated disease management, self-management, and structured follow-up intervention (IDM) for high-risk patients with COPD in primary care. This was a one-year multi-center randomized controlled trial. High-risk, exacerbation-prone COPD patients were randomized to IDM provided by a certified respiratory educator and physician, or usual physician care. IDM received case management, self-management education, and skills training. The primary outcome, COPD-related QoL, was measured using the COPD Assessment Test (CAT). Of 180 patients randomized from 8 sites, 81.1% completed the study. Patients were 53.6% women, mean age 68.2 years, post-bronchodilator FEV(1) 52.8% predicted, and 77.4% were Global Initiative for Obstructive Lung Disease Stage D. QoL-CAT scores improved in IDM patients, 22.6 to 14.8, and worsened in usual care, 19.3 to 22.0, adjusted difference 9.3 (p < 0.001). Secondary outcomes including the Clinical COPD Questionnaire, Bristol Knowledge Questionnaire, and FEV1 demonstrated differential improvements in favor of IDM of 1.29 (p < 0.001), 29.6% (p < 0.001), and 100 mL, respectively (p = 0.016). Compared to usual care, significantly fewer IDM patients had a severe exacerbation, −48.9% (p < 0.001), required an urgent primary care visit for COPD, −30.2% (p < 0.001), or had an emergency department visit, −23.6% (p = 0.001). We conclude that IDM self-management and structured follow-up substantially improved QoL, knowledge, FEV1, reduced severe exacerbations, and HSU, in a high-risk primary care COPD population. Clinicaltrials.gov NCT02343055. |
format | Online Article Text |
id | pubmed-6438975 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-64389752019-04-01 The impact of integrated disease management in high-risk COPD patients in primary care Ferrone, Madonna Masciantonio, Marcello G. Malus, Natalie Stitt, Larry O’Callahan, Tim Roberts, Zofe Johnson, Laura Samson, Jim Durocher, Lisa Ferrari, Mark Reilly, Margo Griffiths, Kelly Licskai, Christopher J. NPJ Prim Care Respir Med Article Patients with chronic obstructive pulmonary disease (COPD) have a reduced quality of life (QoL) and exacerbations that drive health service utilization (HSU). A majority of patients with COPD are managed in primary care. Our objective was to evaluate an integrated disease management, self-management, and structured follow-up intervention (IDM) for high-risk patients with COPD in primary care. This was a one-year multi-center randomized controlled trial. High-risk, exacerbation-prone COPD patients were randomized to IDM provided by a certified respiratory educator and physician, or usual physician care. IDM received case management, self-management education, and skills training. The primary outcome, COPD-related QoL, was measured using the COPD Assessment Test (CAT). Of 180 patients randomized from 8 sites, 81.1% completed the study. Patients were 53.6% women, mean age 68.2 years, post-bronchodilator FEV(1) 52.8% predicted, and 77.4% were Global Initiative for Obstructive Lung Disease Stage D. QoL-CAT scores improved in IDM patients, 22.6 to 14.8, and worsened in usual care, 19.3 to 22.0, adjusted difference 9.3 (p < 0.001). Secondary outcomes including the Clinical COPD Questionnaire, Bristol Knowledge Questionnaire, and FEV1 demonstrated differential improvements in favor of IDM of 1.29 (p < 0.001), 29.6% (p < 0.001), and 100 mL, respectively (p = 0.016). Compared to usual care, significantly fewer IDM patients had a severe exacerbation, −48.9% (p < 0.001), required an urgent primary care visit for COPD, −30.2% (p < 0.001), or had an emergency department visit, −23.6% (p = 0.001). We conclude that IDM self-management and structured follow-up substantially improved QoL, knowledge, FEV1, reduced severe exacerbations, and HSU, in a high-risk primary care COPD population. Clinicaltrials.gov NCT02343055. Nature Publishing Group UK 2019-03-28 /pmc/articles/PMC6438975/ /pubmed/30923313 http://dx.doi.org/10.1038/s41533-019-0119-9 Text en © The Author(s) 2019 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Article Ferrone, Madonna Masciantonio, Marcello G. Malus, Natalie Stitt, Larry O’Callahan, Tim Roberts, Zofe Johnson, Laura Samson, Jim Durocher, Lisa Ferrari, Mark Reilly, Margo Griffiths, Kelly Licskai, Christopher J. The impact of integrated disease management in high-risk COPD patients in primary care |
title | The impact of integrated disease management in high-risk COPD patients in primary care |
title_full | The impact of integrated disease management in high-risk COPD patients in primary care |
title_fullStr | The impact of integrated disease management in high-risk COPD patients in primary care |
title_full_unstemmed | The impact of integrated disease management in high-risk COPD patients in primary care |
title_short | The impact of integrated disease management in high-risk COPD patients in primary care |
title_sort | impact of integrated disease management in high-risk copd patients in primary care |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6438975/ https://www.ncbi.nlm.nih.gov/pubmed/30923313 http://dx.doi.org/10.1038/s41533-019-0119-9 |
work_keys_str_mv | AT ferronemadonna theimpactofintegrateddiseasemanagementinhighriskcopdpatientsinprimarycare AT masciantoniomarcellog theimpactofintegrateddiseasemanagementinhighriskcopdpatientsinprimarycare AT malusnatalie theimpactofintegrateddiseasemanagementinhighriskcopdpatientsinprimarycare AT stittlarry theimpactofintegrateddiseasemanagementinhighriskcopdpatientsinprimarycare AT ocallahantim theimpactofintegrateddiseasemanagementinhighriskcopdpatientsinprimarycare AT robertszofe theimpactofintegrateddiseasemanagementinhighriskcopdpatientsinprimarycare AT johnsonlaura theimpactofintegrateddiseasemanagementinhighriskcopdpatientsinprimarycare AT samsonjim theimpactofintegrateddiseasemanagementinhighriskcopdpatientsinprimarycare AT durocherlisa theimpactofintegrateddiseasemanagementinhighriskcopdpatientsinprimarycare AT ferrarimark theimpactofintegrateddiseasemanagementinhighriskcopdpatientsinprimarycare AT reillymargo theimpactofintegrateddiseasemanagementinhighriskcopdpatientsinprimarycare AT griffithskelly theimpactofintegrateddiseasemanagementinhighriskcopdpatientsinprimarycare AT licskaichristopherj theimpactofintegrateddiseasemanagementinhighriskcopdpatientsinprimarycare AT theimpactofintegrateddiseasemanagementinhighriskcopdpatientsinprimarycare AT ferronemadonna impactofintegrateddiseasemanagementinhighriskcopdpatientsinprimarycare AT masciantoniomarcellog impactofintegrateddiseasemanagementinhighriskcopdpatientsinprimarycare AT malusnatalie impactofintegrateddiseasemanagementinhighriskcopdpatientsinprimarycare AT stittlarry impactofintegrateddiseasemanagementinhighriskcopdpatientsinprimarycare AT ocallahantim impactofintegrateddiseasemanagementinhighriskcopdpatientsinprimarycare AT robertszofe impactofintegrateddiseasemanagementinhighriskcopdpatientsinprimarycare AT johnsonlaura impactofintegrateddiseasemanagementinhighriskcopdpatientsinprimarycare AT samsonjim impactofintegrateddiseasemanagementinhighriskcopdpatientsinprimarycare AT durocherlisa impactofintegrateddiseasemanagementinhighriskcopdpatientsinprimarycare AT ferrarimark impactofintegrateddiseasemanagementinhighriskcopdpatientsinprimarycare AT reillymargo impactofintegrateddiseasemanagementinhighriskcopdpatientsinprimarycare AT griffithskelly impactofintegrateddiseasemanagementinhighriskcopdpatientsinprimarycare AT licskaichristopherj impactofintegrateddiseasemanagementinhighriskcopdpatientsinprimarycare AT impactofintegrateddiseasemanagementinhighriskcopdpatientsinprimarycare |